Archives

by in
Entry Author Date Location
Genomatica Files for IPO, Tandem Diabetes Raises $12M, Zogenix Looks to Raise Almost $50M, & More San Diego Life Sciences News 08/25/11 San Diego
Dendreon Adds Ex-ImClone CEO to Board 08/22/11 Seattle
Dendreon’s Blow-Up, Epigenomics Leaves Town, Presage Adds $1.5M, & More Seattle-Area Life Sciences News 08/11/11 Seattle
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus 08/08/11 National
An Open Letter to Dendreon’s Chairman 08/05/11 Seattle
OncoGenex Drops on Trial Delay 08/05/11 Seattle
Dendreon Takes Huge Hit, Stock Tanks 60% on Sales Shortfall 08/03/11 Seattle
Dendreon, After Yearlong Inquiry, Sways Medicare to Pay for $93,000 Prostate Cancer Drug 06/30/11 Seattle
Gates Bets on Computer Drug Discovery, Tachi Yamada Joins Frazier, Dendreon’s LA OK, & More in Seattle-Area Life Sciences News 06/30/11 Seattle
Dendreon Gets FDA Nod for New LA Cancer Drug Factory 06/29/11 Seattle
Exelixis Zeroes in on Lead Drug, Sees Activity in the Bones of Prostate Cancer Patients 06/06/11 San Francisco
Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer 05/24/11 Seattle
The Resurgence of Gene and Cell Therapy 05/16/11 Seattle
Varian Invests $15M in Augmenix 05/12/11 Boston
Dendreon Gets $28M Revenue in Q1 05/02/11 Seattle
J&J Wins Early Approval of Potential Prostate Cancer Blockbuster 04/29/11 New York
San Diego’s Polaris Moves to Late-Stage Test of Drug for Liver Cancer and Other “Arginine-Dependant” Tumors 04/27/11 San Diego
Medivation Flunks Huntington’s Trial, Calibra Nabs Venture Cash, Open Source Biology Comes to SF, & More Bay Area Life Sciences News 04/15/11 San Francisco
T2 Biosystems, On-Q-ity, and GnuBIO Report Progress in Hunting for Signs of Disease 04/07/11 Boston
Dendreon Wins Full Reimbursement From Medicare for $93K Prostate Cancer Drug 03/30/11 Seattle
Tekmira Sues Alnylam, Alan Aderem Bolts to Seattle BioMed, Dendreon’s Warhorse Retires, & More Seattle-Area Life Sciences News 03/17/11 Seattle
Dendreon’s Warhorse, Chief Scientific Officer Dave Urdal, To Retire at Year-End 03/11/11 Seattle
Exelixis Pockets $156M in Stock Sale, Riding Wave of Prostate Cancer Drug Results 03/09/11 San Francisco
Calypso Medical’s New CEO Seeks to Steady Ship After a Rough Couple of Years 03/09/11 Seattle
Dendreon Makes It Official, Grabs Downtown Office and Former Zymo Lab Building 03/01/11 Seattle
Metamark, Stealthy Startup with Dana-Farber Roots, Seeks to Tell Docs When to Treat Prostate Cancer, and When Not 02/24/11 Boston
Dendreon Scopes Out Downtown Seattle Headquarters 02/18/11 Seattle
Genomic Health, Taking a Hit on Bottom Line, Bets Next-Gen Sequencing Will Yield Next-Gen Diagnostics 02/15/11 San Francisco
Calypso Pulls in $6.4M 01/21/11 Seattle
Dendreon Plans to Go It Alone in Europe, Build Provenge Factory in Germany 01/07/11 Seattle
Page 2 of 7 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.